Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026)

Ardelyx's (ARDX) quarterly Cash from Financing Activities came in at $5.4 million in Q1 2026, up 267.21% YoY from $1.5 million in Q1 2025, and up 877.02% on a QoQ basis from $557000.0 in Q4 2025.

Ardelyx (ARDX) Cash from Financing Activities (2014 - 2026) Analysis & Trends

Ardelyx (ARDX) has 13 years of Cash from Financing Activities data on file, last reported at $5.4 million in Q1 2026.

  • Quarterly Cash from Financing Activities rose 267.21% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.5 million (up 6.11% YoY) and the FY2025 annual result came in at $54.5 million, down 48.86% from the prior year.
  • Cash from Financing Activities improved to $5.4 million in Q1 2026, from $557000.0 in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $57.9 million in Q3 2023 to a low of -$63000.0 in Q1 2022.
  • A 5-year average of $22.8 million and a median of $18.8 million in 2022 frame the typical range for Cash from Financing Activities.
  • Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 100.18% — and 2023, when it jumped 80923.81%.
  • Tracing ARDX's Cash from Financing Activities over 5 years: stood at $18.8 million in 2022, then surged by 38.33% to $26.0 million in 2023, then soared by 89.75% to $49.3 million in 2024, then slumped by 98.87% to $557000.0 in 2025, then jumped by 877.02% to $5.4 million in 2026.
  • The last three Cash from Financing Activities figures came in at $5.4 million (Q1 2026), $557000.0 (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 2.42 Bn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -6.05 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -207,909.22
7 Royalty Pharma 33.72 Bn 35.84 Bn - -273.15 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 36.24 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 27.18 Mn
10 Ardelyx 1.01 Bn 729.71 Mn 115.12 Mn 49.72 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 49.72 Mn
Jun 30, 2026 49.72 Mn
Mar 31, 2026 5.44 Mn
Mar 31, 2026 5.44 Mn
Dec 31, 2025 557,000.00
Dec 31, 2025 557,000.00
Sep 30, 2025 2.81 Mn
Sep 30, 2025 2.81 Mn
Jun 30, 2025 49.66 Mn
Jun 30, 2025 49.66 Mn
Mar 31, 2025 1.48 Mn
Mar 31, 2025 1.48 Mn
Dec 31, 2024 49.31 Mn
Dec 31, 2024 49.31 Mn
Sep 30, 2024 2.70 Mn
Sep 30, 2024 2.70 Mn
Jun 30, 2024 1.61 Mn
Jun 30, 2024 1.61 Mn
Mar 31, 2024 52.97 Mn
Mar 31, 2024 52.97 Mn